Luis Santiago
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Luis Santiago has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Margarida Gonçalo
Department of Dermatology University Hospital, Unidade Local de Saude de Coimbra Coimbra Portugal
6 shared publications - Francisca Morgado
Serviço de Dermatologia, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
3 shared publications - Francisca Alves
Serviço de Dermatologia, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
2 shared publications José C. Cardoso
Dermatology Department Coimbra Hospital and University Center Coimbra Portugal
2 shared publicationsM. Gonçalo
Department of Dermatology, Coimbra University Hospital, Coimbra, Portugal
2 shared publicationsMargarida Gonçalo
Dermatology Department, Coimbra University Hospital, Coimbra, Portugal; Faculty of Medicine, University of Coimbra, Coimbra, Portugal
2 shared publications
Latest Publications
- 1 April 2021
- Published by JLE in European Journal Of Dermatology
- Vol. 31 (2) , 291-292
sQuiz your knowledge! Facial purpuric lesions after minor trauma
- 1 April 2021
- Published by JLE in European Journal Of Dermatology
- Vol. 31 (2) , 291-292
sQuiz your knowledge! Facial purpuric lesions after minor trauma
- 1 April 2021
- Published by Wiley in International Journal of Dermatology
- Vol. 60 (4) , E120-E121
An elderly man with a lumbar subcutaneous mass
- 1 April 2021
- Published by Wiley in International Journal of Dermatology
- Vol. 60 (4) , E120-E121
An elderly man with a lumbar subcutaneous mass
- 5 March 2021
- Published by Wiley in International Journal of Dermatology
- Vol. 60 (7) , 911-912
Pyoderma gangrenosum of the breast revealing contralateral breast carcinoma
- 5 March 2021
- Published by Wiley in International Journal of Dermatology
- Vol. 60 (7) , 911-912
Pyoderma gangrenosum of the breast revealing contralateral breast carcinoma
- 12 December 2020
- Published by Wiley in International Journal of Dermatology
- Vol. 60 (5) , 634-635
Lymphomatoid papulosis: an unusual clinical presentation
- 12 December 2020
- Published by Wiley in International Journal of Dermatology
- Vol. 60 (5) , 634-635
Lymphomatoid papulosis: an unusual clinical presentation
- 22 June 2020
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 56 (6) , 986-987
Pruritic axillary papules in a 14‐year‐old girl
- 22 June 2020
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 56 (6) , 986-987
Pruritic axillary papules in a 14‐year‐old girl
- Open Access
- 1 May 2020
- Published by Portuguese Society of Dermatology and Venereology in Journal of the Portuguese Society of Dermatology and Venereology
- Vol. 78 (1) , 25-29
A Importância dos Testes Epicutâneos nos Episódios de DRESS: Estudo Comparativo 10 Anos Depois
Introduction: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe cutaneous adverse drug reaction. According on the culprit drug(s), imputability can be confirmed by patch test (PT). Our objective was to evaluate the value of PT in DRESS in the last 10 years, in comparison with our study in the preceding 10 years. Material & Methods: From 2009 to 2018, patients with DRESS performed PT at the Dermatology Department of Coimbra University Hospital, with the main culprit drug(s) and all drugs administered concomitantly or suspected of inducing DRESS flares. Drugs at 1% - 10% pet (Chemotechnique diagnostics®) or from a commercial preparation diluted at 10% pet were patch tested. Results: We studied 41 patients (20 male/ 21 female, mean age 53 years). The main culprits were allopurinol (n=15), antiepileptics (n=14), trimethoprim/ sulfamethoxazole (n=4), salazopyrine (n=3), diclofenac (n=2), antiretrovirals, ezetimibe/simvastatin and strontium ranelate (1 each). In 15 patients other drugs (n=18) were suspected of worsening DRESS, amoxicillin (n=8), ciprofloxacin (n=2), cefoxitin (n=2), levofloxacin, ceftriaxone, ceftazidime, vancomycin, acyclovir and metamizole (1 each). A positive PT to the culprit drug was observed in 10 patients (24.3%), all to antiepileptics. All patients tested for alopurinol had negative results. Positive reactions were observed to drugs related with flares in 12/18 suspected drugs (67%), but not to quinolones. Conclusion: Results were similar to the study conducted 10 years before when 18/56 (32.1%) patients had positive PT, mostly to carbamazepine and other anticonvulsants. Distinct from our previous study, when no tests were performed with the antibiotic series or other drugs used after the initiation of DRESS, we showed that PT can be a valuable tool to diagnose co-sensitisation in DRESS and emphasise the importance of testing all medications taken during the whole episode, even when PT has no value for the main culprit, like allopurinol. Recognising a co-sensitisation can prevent a new DRESS induced by the second drug.
- 1 May 2020
- Published by Portuguese Society of Dermatology and Venereology in Journal of the Portuguese Society of Dermatology and Venereology
- Vol. 78 (1) , 25-29
Open AccessA Importância dos Testes Epicutâneos nos Episódios de DRESS: Estudo Comparativo 10 Anos Depois
Introduction: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe cutaneous adverse drug reaction. According on the culprit drug(s), imputability can be confirmed by patch test (PT). Our objective was to evaluate the value of PT in DRESS in the last 10 years, in comparison with our study in the preceding 10 years. Material & Methods: From 2009 to 2018, patients with DRESS performed PT at the Dermatology Department of Coimbra University Hospital, with the main culprit drug(s) and all drugs administered concomitantly or suspected of inducing DRESS flares. Drugs at 1% - 10% pet (Chemotechnique diagnostics®) or from a commercial preparation diluted at 10% pet were patch tested. Results: We studied 41 patients (20 male/ 21 female, mean age 53 years). The main culprits were allopurinol (n=15), antiepileptics (n=14), trimethoprim/ sulfamethoxazole (n=4), salazopyrine (n=3), diclofenac (n=2), antiretrovirals, ezetimibe/simvastatin and strontium ranelate (1 each). In 15 patients other drugs (n=18) were suspected of worsening DRESS, amoxicillin (n=8), ciprofloxacin (n=2), cefoxitin (n=2), levofloxacin, ceftriaxone, ceftazidime, vancomycin, acyclovir and metamizole (1 each). A positive PT to the culprit drug was observed in 10 patients (24.3%), all to antiepileptics. All patients tested for alopurinol had negative results. Positive reactions were observed to drugs related with flares in 12/18 suspected drugs (67%), but not to quinolones. Conclusion: Results were similar to the study conducted 10 years before when 18/56 (32.1%) patients had positive PT, mostly to carbamazepine and other anticonvulsants. Distinct from our previous study, when no tests were performed with the antibiotic series or other drugs used after the initiation of DRESS, we showed that PT can be a valuable tool to diagnose co-sensitisation in DRESS and emphasise the importance of testing all medications taken during the whole episode, even when PT has no value for the main culprit, like allopurinol. Recognising a co-sensitisation can prevent a new DRESS induced by the second drug.
- Open Access
- 11 January 2020
- Published by Portuguese Society of Dermatology and Venereology in Journal of the Portuguese Society of Dermatology and Venereology
- Vol. 77 (4) , 345-347
Brain Injury Associated with Chronic Spontaneous Urticaria: a Kounis-Like Syndrome?
‘Kounis Syndrome’ is an acute coronary artery event due to an artery spasm occurring during immediate hypersensi- tivity reactions or chronic spontaneous urticaria. Recently it has been reported in other systems, including the cerebral vasculature. We present a case series of three patients observed between January 2016 and December 2018 with acute and transient brain injury associated with concomitant exacerbation of chronic spontaneous urticaria, including one patient with multiple recurrences of neurologic symptoms during exacerbations of urticaria. Minor imaging defects were observed in two patients, but there were no apparent vascular risk factors or coagulation abnormalities that might explain neurologic symptoms. Chronic spontaneous urticaria, through activation of mast cells and mediator release, seems capable of inducing cerebral arterial aggression. The authors want to call the attention to this possible association, reinforcing the need to keep urticaria under control to prevent neurological manifestations.
- 11 January 2020
- Published by Portuguese Society of Dermatology and Venereology in Journal of the Portuguese Society of Dermatology and Venereology
- Vol. 77 (4) , 345-347
Open AccessBrain Injury Associated with Chronic Spontaneous Urticaria: a Kounis-Like Syndrome?
‘Kounis Syndrome’ is an acute coronary artery event due to an artery spasm occurring during immediate hypersensi- tivity reactions or chronic spontaneous urticaria. Recently it has been reported in other systems, including the cerebral vasculature. We present a case series of three patients observed between January 2016 and December 2018 with acute and transient brain injury associated with concomitant exacerbation of chronic spontaneous urticaria, including one patient with multiple recurrences of neurologic symptoms during exacerbations of urticaria. Minor imaging defects were observed in two patients, but there were no apparent vascular risk factors or coagulation abnormalities that might explain neurologic symptoms. Chronic spontaneous urticaria, through activation of mast cells and mediator release, seems capable of inducing cerebral arterial aggression. The authors want to call the attention to this possible association, reinforcing the need to keep urticaria under control to prevent neurological manifestations.
- 3 January 2020
- Published by Wiley in Contact Dermatitis
- Vol. 82 (5) , 290-296
Hypersensitivity to antibiotics in drug reaction with eosinophilia and systemic symptoms (DRESS) from other culprits
Background: Antibiotics have been implicated in the reactivation of exanthema and systemic involvement in drug reaction with eosinophilia and systemic symptoms (DRESS); however, it is not clear whether these patients become sensitized to the antibiotic.Objective: To evaluate if, after DRESS, patients become sensitized to antibiotics.Methods: We retrospectively reviewed the patch test (PT) data and clinical files of DRESS patients who were administered antibiotics during DRESS from other culprits.Results: Nine patients out of 17 (53%) were positive to antibiotics in PT: six to the penicillin group and three to cephalosporins (including one patient with additional positivity to vancomycin). Considering the eight patients who were negative to antibiotics in PT, seven were exposed to a fluoroquinolone. Four cases were patch tested again and three remained positive to antibiotics 2 to 5 years thereafter. Two patients with positive PT results had an accidental re‐exposure to antibiotics and developed a maculopapular exanthema without systemic symptoms.Conclusion: Exposure to antibiotics during DRESS or its prodromal phase could enhance sensitization to antibiotics, as confirmed by a positive PT. Reproducibility of positive PTs to antibiotics after several years and reactivation after re‐exposure support that T‐cell‐mediated hypersensitivity to antibiotics in the setting of DRESS is a specific reaction.
- 3 January 2020
- Published by Wiley in Contact Dermatitis
- Vol. 82 (5) , 290-296
Hypersensitivity to antibiotics in drug reaction with eosinophilia and systemic symptoms (DRESS) from other culprits
Background: Antibiotics have been implicated in the reactivation of exanthema and systemic involvement in drug reaction with eosinophilia and systemic symptoms (DRESS); however, it is not clear whether these patients become sensitized to the antibiotic.Objective: To evaluate if, after DRESS, patients become sensitized to antibiotics.Methods: We retrospectively reviewed the patch test (PT) data and clinical files of DRESS patients who were administered antibiotics during DRESS from other culprits.Results: Nine patients out of 17 (53%) were positive to antibiotics in PT: six to the penicillin group and three to cephalosporins (including one patient with additional positivity to vancomycin). Considering the eight patients who were negative to antibiotics in PT, seven were exposed to a fluoroquinolone. Four cases were patch tested again and three remained positive to antibiotics 2 to 5 years thereafter. Two patients with positive PT results had an accidental re‐exposure to antibiotics and developed a maculopapular exanthema without systemic symptoms.Conclusion: Exposure to antibiotics during DRESS or its prodromal phase could enhance sensitization to antibiotics, as confirmed by a positive PT. Reproducibility of positive PTs to antibiotics after several years and reactivation after re‐exposure support that T‐cell‐mediated hypersensitivity to antibiotics in the setting of DRESS is a specific reaction.
- 27 December 2019
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 61 (2) , E241-E243
The clinical spectrum of dermatomyositis and the new autoantibodies – with regard to two clinical cases with distinct associations
Dermatomyositis is a rare idiopathic inflammatory myopathy associated with different autoantibodies (anti‐MDA5, anti‐TIF1‐γ) which are linked with typical and distinct phenotypes of dermatomyositis. We describe two cases that illustrate these diverse cutaneous and systemic manifestations.
- 27 December 2019
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 61 (2) , E241-E243
The clinical spectrum of dermatomyositis and the new autoantibodies – with regard to two clinical cases with distinct associations
Dermatomyositis is a rare idiopathic inflammatory myopathy associated with different autoantibodies (anti‐MDA5, anti‐TIF1‐γ) which are linked with typical and distinct phenotypes of dermatomyositis. We describe two cases that illustrate these diverse cutaneous and systemic manifestations.
- 19 November 2019
- Published by Wiley in Contact Dermatitis
- Vol. 82 (3) , 190-191
Safe use of imipenem after delayed hypersensitivity to meropenem—Value of patch tests
- 19 November 2019
- Published by Wiley in Contact Dermatitis
- Vol. 82 (3) , 190-191
Safe use of imipenem after delayed hypersensitivity to meropenem—Value of patch tests